Location · Winston-Salem, NC
Clinical trials in Winston-Salem, NC
133 recruiting studies have a site in Winston-Salem, and 45 of them accept healthy volunteers.
133 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Winston-Salem, NC + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
- Location
- Winston-Salem, NC + 73 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
FiberLocker® System Augmentation of Rotator Cuff Repairs
ZuriMED Technologies Inc.
- Location
- Winston-Salem, NC + 3 other US sites
- Eligibility basics
- Ages 30–70
- Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Medtronic Cardiovascular
- Location
- Winston-Salem, NC + 27 other US sites
- Eligibility basics
- Ages 20+
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Winston-Salem, NC + 29 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Winston-Salem, NC + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Ardelyx
- Location
- Winston-Salem, NC + 108 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Use of CereGate Therapy for Freezing of Gait in PD
CereGate Inc.
- Location
- Winston-Salem, NC + 6 other US sites
- Eligibility basics
- Ages 21–80
- RecruitingPhase 1/Phase 2
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
AbbVie
- Location
- Winston-Salem, NC + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Krystal Biotech, Inc.
- Location
- Winston-Salem, NC + 5 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR®) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain…
Renovo Concepts, Inc.
- Location
- Winston-Salem, NC + 2 other US sites
- Eligibility basics
- Ages 22–65
- RecruitingPhase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Direct Biologics, LLC
- Location
- Winston-Salem, NC + 30 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Coologics, Inc
- Location
- Winston-Salem, NC + 7 other US sites
- Eligibility basics
- Ages 22–49 · Women only
- Recruiting
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
InMode MD Ltd.
- Location
- Winston-Salem, NC + 4 other US sites
- Eligibility basics
- Ages 22–80 · Women only
- RecruitingPhase 2
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Vaneltix Pharma, Inc.
- Location
- Winston-Salem, NC + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda
- Location
- Winston-Salem, NC + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Neurona Therapeutics
- Location
- Winston-Salem, NC + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited
- Location
- Winston-Salem, NC + 11 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Winston-Salem, NC + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
BioRestorative Therapies
- Location
- Winston-Salem, NC + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Impax Laboratories, LLC
- Location
- Winston-Salem, NC + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Winston-Salem, NC + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 3
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Vivacelle Bio
- Location
- Winston-Salem, NC + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Matrix Biomed, Inc.
- Location
- Winston-Salem, NC + 7 other US sites
- Eligibility basics
- Ages 18+